Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 12, 2008, Pages 1860-1868

  Nishihara, Yunosuke ^a   Aishima, Shinichi ^a,b   Kuroda, Yousuke ^a   Iguchi, Tomohiro ^a   Taguchi, Kenichi ^c   Asayama, Yoshiki ^a   Taketomi, Akinobu ^a   Kinukawa, Naoko ^a   Honda, Hiroshi ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HAMANOMACHI HOSPITAL   (Japan)

^c NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Biliary phenotype; Hepatocellular carcinoma; Transcatheter arterial chemoembolization

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 19; CYTOKERATIN 7; VIMENTIN;

ARTICLE; CHEMOEMBOLIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; PHENOTYPE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 57049174430     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05601.x     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001 94 : 153 6.
2. Chang JM, Tzeng WS, Pan HB, Yang CF, Lai KH. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer 1994 74 : 2449 53.
3. Matsui O, Kadoya M, Yoshikawa J et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993 188 : 79 83.
4. Nagasue N, Galizia G, Kohno H et al. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery 1989 106 : 81 6.
5. Sugo H, Futagawa S, Beppu T, Fukasawa M, Kojima K. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J. Surg. 2003 27 : 1295 9.
6. Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000 89 : 2606 12.
7. Kojiro M, Sugihara S, Kakizoe S, Nakashima O, Kiyomatsu K. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemother. Pharmacol. 1989 23 : S4 S8.
8. Eyken PV, Sciot R, Paterson A, Callea F, Kew MC, Desmet VJ. Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum. Pathol. 1988 19 : 562 8.
9. Aishima S, Nishihara Y, Kuroda Y et al. Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma. Am. J. Surg. Pathol. 2007 31 : 783 91.
10. Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin. Cell Dev. Biol. 2002 13 : 389 96.
11. Libbrecht L, Desmet V, Damme BV, Roskams T. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J. Hepatol. 2000 33 : 76 84.
12. Haruna Y, Saito K, Spaulding S, Nalesnik MA, Gerber MA. Identification of bipotential progenitor cells in human liver development. Hepatology 1996 23 : 476 81.
13. Kakizoe S, Kojiro M, Nakashima T. Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer 1987 59 : 310 16.
14. Nishi H, Taguchi K, Asayama Y et al. Sarcomatous hepatocellular carcinoma: a special reference to ordinary hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2003 18 : 415 23.
15. Hamilton SR, Aaltonen LA. WHO Classification. Tumours of the Digestive System. Lyon : IARC Press, 2000.
16. Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum. Pathol. 1995 26 : 956 64.
17. Liver Cancer Study Group. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 4th edn. Tokyo : Kanehara Publications, 2000.
18. Takayasu K, Muramatsu Y, Maeda T et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am. J. Roentgenol. 2001 176 : 681 8.
19. Ikai I, Arii S, Ichida T et al. Report of the 16th follow-up survey of primary liver cancer. Hepatol. Res. 2005 32 : 163 72.
20. Veltri A, Grosso M, Martina MC et al. Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study. Cardiovasc. Intervent. Radiol. 1998 21 : 393 8.
21. Llovet JM, Real MI, Montana X et al. Carcelona Clinic Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002 359 : 1734 9.
22. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002 35 : 1164 71.
23. Higuchi T, Kikuchi M, Okazaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization: a histopathologic study of 84 resected cases. Cancer 1994 73 : 2259 67.
24. Kim YB, Park YN, Park C. Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. Histopathology 2001 38 : 160 6.
25. Koda M, Maeda Y, Matsunaga Y, Miura K, Murawaki Y, Horie Y. Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma. Hepatol. Res. 2003 27 : 163 7.
26. Takada Y, Kurata M, Ohkohchi N. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int. J. Clin. Oncol. 2003 8 : 332 5.
27. Hu L, Lau SH, Tzang CH et al. Association of vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 2004 23 : 298 302.
28. Denk H, Stumptner C, Fuchsbichler A et al. Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related? J. Pathol. 2006 208 : 653 61.
29. Norkin SA, Campagna-Pinto D. Cytoplasmic hyaline inclusions in hepatoma. Histochemical study. Arch. Pathol. 1968 86 : 25 32.
30. Durnez A, Verslype C, Nevens F et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006 49 : 138 51.
31. Uenishi T, Kubo S, Yamamoto T et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003 94 : 851 7.
32. Wu PC, Fang JWS, Lau VKT, Lai CL, Lo CK, Lau JYN. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers: clinical and biological implications. Am. J. Pathol. 1996 149 : 1167 75.
33. Lee JS, Heo J, Libbrecht L et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat. Med. 2006 12 : 410 16.
34. Wu PC, Lai VC, Fang JW, Gerber MA, Lai CL, Lau JY. Hepatocellular carcinoma expressing both hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells. J. Hepatol. 1999 31 : 965 6.
35. Bisgaard HC, Parmelee DC, Dunsford HA, Sechi S, Thorgeirsson SS. Keratin 14 protein in cultured nonparenchymal rat hepatic epithelial cells: characterization of keratin 14 and keratin 19 as antigens for the commonly used mouse monoclonal antibody OV-6. Mol. Carcinog. 1993 7 : 60 6.
36. Roskams T. Liver stem cells and implication in hepatocellular and cholangiocarcinoma. Oncogene 2006 25 : 3818 22.
37. Theise ND, Saxena R, Portmann BC et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999 30 : 1425 33.
38. Roskams T, Yang SQ, Koteish A et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am. J. Pathol. 2003 163 : 1301 11.
39. Seki S, Kitada T, Sakaguchi H et al. Expression of progenitor cell markers in livers with fulminant massive necrosis. Hepatol. Res. 2003 25 : 149 57.
40. Xiao JC, Ruck P, Adam A, Wang TX, Kaiserling E. Small epithelial cells in human liver cirrhosis exhibit features of hepatic stem-like cells: immunohistochemical, electron microscopic and immunoelectron microscopic findings. Histopathology 2003 42 : 141 9.